Ondine Biomedical Inc. (AIM:OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
9.75
0.00 (0.00%)
Sep 29, 2026, 5:15 PM GMT

Ondine Biomedical Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-33.12-29.52-19.1-14.41-19.37-50.09
Depreciation & Amortization
0.570.590.570.590.490.51
Other Amortization
----1.33-
Loss (Gain) From Sale of Assets
---0.10.08-
Stock-Based Compensation
1.691.731.850.641.454.06
Other Operating Activities
0.39-0.45-0.72-0.27-0.4332.84
Change in Accounts Receivable
0.040.05-0.19-0.140.070.3
Change in Inventory
-0.89-1.03-0.330.1-0.34-0.67
Change in Accounts Payable
4.314.82.53-0.420.252.15
Change in Other Net Operating Assets
0.03-0.03-0.110.160.13-1.65
Operating Cash Flow
-26.99-23.85-15.49-13.65-16.35-12.54
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.21-0.12-0.01-0.18-0.31-0.08
Investing Cash Flow
-0.21-0.12-0.01-0.18-0.31-0.08

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--1.65--2.83
Long-Term Debt Issued
-----4.25
Total Debt Issued
--1.65--7.08
Short-Term Debt Repaid
---0.54---0.65
Long-Term Debt Repaid
--0.38-0.43-0.43-0.25-0.29
Lease Payments
-0.32-0.38-0.43-0.39-0.25-0.26
Total Debt Repaid
-0.32-0.38-0.96-0.43-0.25-0.94
Net Debt Issued (Repaid)
-0.32-0.380.69-0.43-0.256.14
Issuance of Common Stock
29.3425.9822.984.91-37.73
Repurchase of Common Stock
------0.8
Other Financing Activities
-2.07-1.38-1.93-0.7-0.02-1.17
Financing Cash Flow
26.9624.2221.743.79-0.2841.9

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-00.390.55-0.090.34-0.05
Net Cash Flow
-0.250.646.79-10.13-16.629.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-27.2-23.96-15.5-13.83-16.66-12.62
Free Cash Flow Growth
------
Free Cash Flow Margin
-945.00%-905.67%-756.47%-1149.63%-2610.66%-491.13%
Free Cash Flow Per Share
-0.05-0.05-0.06-0.07-0.09-0.16
Levered Free Cash Flow
-14.96-12.11-7.75-8.44-7.88-6.11
Unlevered Free Cash Flow
-14.94-12.09-7.73-8.41-7.86-6.11
Free Cash Flow After Leases
-27.52-24.34-15.93-14.22-16.91-12.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.01-0.02-
Change in Working Capital
3.483.81.91-0.30.10.13